Press "Enter" to skip to content

New patent for Allergan Holdings drug VIBERZI

0
Copyright © DrugPatentWatch. Originally published at New patent for Allergan Holdings drug VIBERZI

Annual Drug Patent Expirations for VIBERZI
Annual Drug Patent Expirations for VIBERZI

Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

VIBERZI drug price trends.

Drug patent litigation for VIBERZI.

This drug has one hundred and three patent family members in thirty-five countries.

The generic ingredient in VIBERZI is eluxadoline. One supplier is listed for this compound. Additional details are available on the eluxadoline profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Allergan Holdings drug VIBERZI
    Do NOT follow this link or you will be banned from the site!